SCHEMBL12371006

SCHEMBL12371006

O=C1CC(C2CCC(c3ccc(OC(F)(F)F)cc3)CC2)O1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.43
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
GRM2 Q14416 2/20 0.38
TEAD1 P28347 2/20 0.38
EPHX2 P34913 2/20 0.36
FAAH O00519 1/20 0.35
PDE9A O76083 1/20 0.35
KDM1A O60341 1/20 0.35
RCOR1 Q9UKL0 1/20 0.35
DHODH Q02127 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
CNR1 P21554 1/20 0.34
F2R P25116 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
FFAR4 Q5NUL3 1/20 0.34
WNT3A P56704 1/20 0.34
TNKS2 Q9H2K2 1/20 0.34
PIM1 P11309 1/20 0.33
PIM2 Q9P1W9 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12370946 0.99 L3MBTL1 (0.43) L3MBTL1MEN1KMT2AGRM2TEAD1
SCHEMBL12371023 0.96 L3MBTL1 (0.46) L3MBTL1MEN1KMT2AGRM2TEAD1
SCHEMBL12371032 0.83 NOTUM (0.38) TEAD1
SCHEMBL12371048 0.81 ALDH1A1 (0.44) MEN1KMT2A
SCHEMBL12371002 0.81 EPHX2 (0.36) EPHX2FFAR4
SCHEMBL4564168 0.80 L3MBTL1 (0.47) L3MBTL1MEN1KMT2AGRM2EPHX2
SCHEMBL12371049 0.79 ALDH1A1 (0.41) L3MBTL1MEN1KMT2ATEAD1
SCHEMBL12370993 0.79 MAP1LC3B (0.39) L3MBTL1GRM2
SCHEMBL12371058 0.78 FFAR4 (0.31) FFAR4
SCHEMBL9049167 0.78 L3MBTL1 (0.46) L3MBTL1MEN1KMT2AGRM2EPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7999123-B2 2-oxetanone derivative and process for production thereof JNC CORPORATION (JP) 2011-08-16 US disclosed
US-7999123-B2 2-oxetanone derivative and process for production thereof JNC CORPORATION (JP) 2011-08-16 US disclosed
US-20090275756-A1 2-OXETANONE DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF CHISSO CORPORATION (JP) 2009-11-05 US disclosed
US-20090275756-A1 2-OXETANONE DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF CHISSO CORPORATION (JP) 2009-11-05 US disclosed
EP-2020407-A1 2-OXETANONE DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF Chisso Corporation (JP) 2009-02-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275756-A1 2-OXETANONE DERIVATIVE AND PROCESS FOR PRODUCTION THEREOF OGDH, OXGR1, OXER1 L3MBTL1 3749/4885MEN1 2309/4885KMT2A 342/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.